143 related articles for article (PubMed ID: 28138712)
1. Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis.
Yu SB; Gao Q; Lin WW; Kang MQ
Mol Med Rep; 2017 Mar; 15(3):1236-1242. PubMed ID: 28138712
[TBL] [Abstract][Full Text] [Related]
2. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
[TBL] [Abstract][Full Text] [Related]
3. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
5. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
6. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.
Li X; Zheng S; Liu Q; Liu T; Liang M; Gao X; Lu M; Sheyhidin I; Lu X
Mol Carcinog; 2015 Sep; 54(9):779-88. PubMed ID: 24668792
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics.
Uemura N; Nakanishi Y; Kato H; Saito S; Nagino M; Hirohashi S; Kondo T
Int J Cancer; 2009 May; 124(9):2106-15. PubMed ID: 19142970
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
12. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.
Fu L; Qin YR; Xie D; Chow HY; Ngai SM; Kwong DL; Li Y; Guan XY
Cancer; 2007 Dec; 110(12):2672-81. PubMed ID: 17960614
[TBL] [Abstract][Full Text] [Related]
13. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma.
Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS
Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885
[TBL] [Abstract][Full Text] [Related]
14. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic analysis of esophageal squamous cell carcinoma.
Qi Y; Chiu JF; Wang L; Kwong DL; He QY
Proteomics; 2005 Jul; 5(11):2960-71. PubMed ID: 15986332
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
